Skip to main content

Client News

Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need

29th March 2023

Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry

28th March 2023

ONWARD: convocation of the 2023 annual general meeting of shareholders and proposed resolutions

28th March 2023

ONWARD reports 2022 full year financial and operating results

28th March 2023

Apogenix’ partner CANbridge announces 67 % five-year overall survival rate compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients

27th March 2023

Destiny Pharma announces publication of XF-73 nasal gel Phase 2 data in leading US journal Infection Control & Hospital Epidemiology

24th March 2023

Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business

24th March 2023

InflaRx reports full year 2022 financial and operating results

22nd March 2023

A new prestigious scientific publication for Carbios marks the expansion of its research to other plastics

21st March 2023

Mainz Biomed to present at Sidoti Virtual Investor Conference March 22-23

21st March 2023